Loading...
Header Logo
Keywords
Last Name
Institution

Robert C Rathbun

TitleProfessor & Chair
InstitutionUniversity of Oklahoma Health Sciences Center
DepartmentPharmacy Clinical & Admin Sci
Address1110 N Stonewall Ave
Oklahoma City OK 73117-1200
Phone405/271-6878
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Durham SH, Badowski ME, Liedtke MD, Rathbun RC, Pecora Fulco P. Acute Care Management of the HIV-Infected Patient: A Report from the HIV Practice and Research Network of the American College of Clinical Pharmacy. Pharmacotherapy. 2017 May; 37(5):611-629. PMID: 28273373.
      View in: PubMed
    2. Liedtke MD, Tomlin CR, Skrepnek GH, Farmer KC, Johnson PN, Rathbun RC. HIV Pharmacist's Impact on Inpatient Antiretroviral Errors. HIV Med. 2016 Nov; 17(10):717-723. PMID: 27038405.
      View in: PubMed
    3. Miller MM, Liedtke MD, Lockhart SM, Rathbun RC. The role of dolutegravir in the management of HIV infection. Infect Drug Resist. 2015; 8:19-29. PMID: 25733917; PMCID: PMC4340460.
    4. Liedtke MD, Tomlin CR, Lockhart SM, Miller MM, Rathbun RC. Long-term efficacy and safety of raltegravir in the management of HIV infection. Infect Drug Resist. 2014; 7:73-84. PMID: 24672249; PMCID: PMC3965364.
    5. Kleyn TJ, Liedtke MD, Harrison DL, Lockhart SM, Salvaggio MR, Ripley TL, Rathbun RC. Incidence of transmitted antiretroviral drug resistance in treatment-naive HIV-1-infected persons in a large South Central United States clinic. Ann Pharmacother. 2014 Apr; 48(4):470-5. PMID: 24473489.
      View in: PubMed
    6. Ripley TL, Adamson PB, Hennebry TA, Van Tuyl JS, Harrison DL, Rathbun RC. Collaborative practice model between cardiologists and clinical pharmacists for management of patients with cardiovascular disease in an outpatient clinic. Ann Pharmacother. 2014 Mar; 48(3):412-9. PMID: 24321852.
      View in: PubMed
    7. Rathbun RC, Lockhart SM, Miller MM, Liedtke MD. Dolutegravir, a second-generation integrase inhibitor for the treatment of HIV-1 infection. Ann Pharmacother. 2014 Mar; 48(3):395-403. PMID: 24259658.
      View in: PubMed
    8. Rathbun RC. HIV consensus guideline recommends antiretroviral treatment regardless of CD4 count, new regimens and possible regimen change for chronic low level viraemia. Evid Based Med. 2013 Aug; 18(4):149-50. PMID: 23154674.
      View in: PubMed
    9. Liedtke MD, Vanguri A, Rathbun RC. A probable interaction between warfarin and the antiretroviral TRIO study regimen. Ann Pharmacother. 2012 Nov; 46(11):e34. PMID: 23115227.
      View in: PubMed
    10. Ripley TL, Hennebry TA, Sanders TN, Harrison D, Rathbun RC. Impact of a clinical pharmacist on a cardiovascular surrogate endpoint: a pilot study. Pharm Pract (Granada). 2012 Jul; 10(3):173-9. PMID: 24155834; PMCID: PMC3780490.
    11. Rathbun RC, Hester EK, Arnold LM, Chung AM, Dunn SP, Harinstein LM, Leber M, Murphy JA, Schonder KS, Wilhelm SM, Smilie KB. Importance of direct patient care in advanced pharmacy practice experiences. Pharmacotherapy. 2012 Apr; 32(4):e88-97. PMID: 22461125.
      View in: PubMed
    12. Rathbun RC, Liedtke MD. Antiretroviral drug interactions: overview of interactions involving new and investigational agents and the role of therapeutic drug monitoring for management. Pharmaceutics. 2011 Oct 21; 3(4):745-81. PMID: 24309307; PMCID: PMC3857057.
    13. Liedtke MD, Rathbun RC. Drug interactions with antiretrovirals and warfarin. Expert Opin Drug Saf. 2010 Mar; 9(2):215-23. PMID: 20095918.
      View in: PubMed
    14. Rathbun CR, Liedtke MD, Blevins SM, Harrison D, Lockhart SM, Salvaggio M, Acosta EP. Electrocardiogram abnormalities with atazanavir and lopinavir/ritonavir. HIV Clin Trials. 2009 Sep-Oct; 10(5):328-36. PMID: 19906626.
      View in: PubMed
    15. Liedtke MD, Rathbun RC. Warfarin-antiretroviral interactions. Ann Pharmacother. 2009 Feb; 43(2):322-8. PMID: 19196837.
      View in: PubMed
    16. Stephens JR, Rathbun RC, Lockhart SM, Bronze MS, Greenfield RA. Part XV. Antiretroviral therapy for human immunodeficiency virus infection. J Okla State Med Assoc. 2007 Nov; 100(11):417-24. PMID: 18183858.
      View in: PubMed
    17. Lockhart SM, Rathbun RC, Stephens JR, Baker DL, Drevets DA, Greenfield RA, Salvaggio MR, Vincent S. Cutaneous reactions with tenofovir disoproxil fumarate: a report of nine cases. AIDS. 2007 Jun 19; 21(10):1370-3. PMID: 17545718.
      View in: PubMed
    18. Rathbun RC, Farmer KC, Lockhart SM, Stephens JR. Validity of a stage of change instrument in assessing medication adherence in indigent patients with HIV infection. Ann Pharmacother. 2007 Feb; 41(2):208-14. PMID: 17213294.
      View in: PubMed
    19. Rathbun RC, Lockhart SM, Stephens JR. Current HIV treatment guidelines--an overview. Curr Pharm Des. 2006; 12(9):1045-63. PMID: 16515485.
      View in: PubMed
    20. Rathbun RC, Farmer KC, Stephens JR, Lockhart SM. Impact of an adherence clinic on behavioral outcomes and virologic response in treatment of HIV infection: a prospective, randomized, controlled pilot study. Clin Ther. 2005 Feb; 27(2):199-209. PMID: 15811483.
      View in: PubMed
    21. Liedtke MD, Lockhart SM, Rathbun RC. Anticonvulsant and antiretroviral interactions. Ann Pharmacother. 2004 Mar; 38(3):482-9. PMID: 14970370.
      View in: PubMed
    22. Moomaw MD, Cornea P, Rathbun RC, Wendel KA. Review of antiviral therapy for herpes labialis, genital herpes and herpes zoster. Expert Rev Anti Infect Ther. 2003 Aug; 1(2):283-95. PMID: 15482124.
      View in: PubMed
    23. Rossi DR, Rathbun RC, Slater LN. Symptomatic orthostasis with extended-release nifedipine and protease inhibitors. Pharmacotherapy. 2002 Oct; 22(10):1312-6. PMID: 12389881.
      View in: PubMed
    24. Rathbun RC, Rossi DR. Low-dose ritonavir for protease inhibitor pharmacokinetic enhancement. Ann Pharmacother. 2002 Apr; 36(4):702-6. PMID: 11918523.
      View in: PubMed
    25. Hoffman HL, Rathbun RC. Review of the safety and efficacy of voriconazole. Expert Opin Investig Drugs. 2002 Mar; 11(3):409-29. PMID: 11866669.
      View in: PubMed
    26. Clay PG, Rathbun RC, Slater LN. Management protocol for abacavir-related hypersensitivity reaction. Ann Pharmacother. 2000 Feb; 34(2):247-9. PMID: 10676833.
      View in: PubMed
    27. Mihm LB, Rathbun RC, Resman-Targoff BH. Hyperkalemia associated with high-dose trimethoprim-sulfamethoxazole in a patient with the acquired immunodeficiency syndrome. Pharmacotherapy. 1995 Nov-Dec; 15(6):793-7. PMID: 8602391.
      View in: PubMed
    28. Morrison YY, Rathbun RC. Hantavirus pulmonary syndrome: the Four Corners disease. Ann Pharmacother. 1995 Jan; 29(1):57-65. PMID: 7711347.
      View in: PubMed
    29. Rathbun RC. Surrogate markers for assessing treatment response in HIV disease. Ann Pharmacother. 1993 Apr; 27(4):450-5. PMID: 8097416.
      View in: PubMed
    30. Rathbun RC, Martin ES. Didanosine therapy in patients intolerant of or failing zidovudine therapy. Ann Pharmacother. 1992 Nov; 26(11):1347-51. PMID: 1362093.
      View in: PubMed
    Rathbun's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _